With the help of its reviewers, ACCP can publish the papers you want to read.

Pharmacotherapy Publications, Inc. appreciates the authors, editorial board members, and reviewers who contribute to the success of ACCP journals. In 2019, more than 550 reviewers contributed their time and expertise to the official journals of ACCP. These individuals are recognized on the JACCP and Pharmacotherapy websites.

Pharmacotherapy closed out 2019 with more than 482,000 downloads. The top 5 papers downloaded in 2019 were:

1. Tsuji BT, Pogue JM, Zavascki AP, et al. International consensus guidelines for the optimal use of the polymyxins: endorsed by the ACCP, ESCMID, IDSA, ISAP, SCCM, and SIDP. Pharmacotherapy 2019;39:10-39.
2. Meng L, Mui E, Holubar MK, et al. Comprehensive guidance for antibiotic dosing in obese adults. Pharmacotherapy 2017;37:1415-31.
3. Reynolds PM, MacLaren R, Mueller SW, et al. Management of extravasation injuries: a focused evaluation of noncytotoxic medications. Pharmacotherapy 2014;34:617-32.
4. Shaeer KM, Zmarlicka MT, Chahine EB, et al. Plazomicin: a next-generation aminoglycoside. Pharmacotherapy 2019;39:77-93.
5. Stanton BE, Barasch NS, Tellor KB. Comparison of the safety and effectiveness of apixaban versus warfarin in patients with severe renal impairment. Pharmacotherapy 2017;37:412-9.

Of the papers first published in Pharmacotherapy in 2018, the top 5 papers downloaded in 2019 were:

1. Tsuji BT, Pogue JM, Zavascki AP, et al. International consensus guidelines for the optimal use of the polymyxins: endorsed by the ACCP, ESCMID, IDSA, ISAP, SCCM, and SIDP. Pharmacotherapy 2019;39:10-39.
2. Shaeer KM, Zmarlicka MT, Chahine EB, et al. Plazomicin: a next-generation aminoglycoside. Pharmacotherapy 2019;39:77-93.
3. Patten DK, Schultz BG, Berlau DJ. The safety and efficacy of low-dose naltrexone in the management of chronic pain and Inflammation in multiple sclerosis, fibromyalgia, Crohn’s disease, and other chronic pain disorders. Pharmacotherapy 2018;38:382-9.
4. Romero-Sandoval EA, Fincham JE, Kolano AL, et al. Cannabis for chronic pain: challenges and considerations. Pharmacotherapy 2018;38:651-62.
5. Barber KE, Bell AM, Wingler MJB, et al. Omadacycline enters the ring: a new antimicrobial contender. Pharmacotherapy 2018;38:1194-204.

JACCP closed out 2019 with 91,000 downloads. The top 5 papers downloaded in 2019 were:

1. Bauman JL, Jackevicius C, Zillich AJ, et al. On the methodology of retrospective chart reviews. J Am Coll Clin Pharm 2019;2:6-7.
2. Somma McGivney MA, Pope DD, Trygstad T. Unrealized potential and unrecognized value: Community-based pharmacy practice is reinventing itself – join the movement. J Am Coll Clin Pharm 2019;2:330-4.
3. Soric MM, Robinson JD, Ulbrich TR. Grade point average is an inappropriate measure of a residency candidate’s knowledge and skills. J Am Coll Clin Pharm 2019;2:177-80.
4. Hammond DA, Flowers HJC, Meena N, et al. Cost avoidance associated with clinical pharmacist presence in a medical intensive care unit. J Am Coll Clin Pharm 2019;2:610-5.
5. Dixon DL, Reed BN. To tweet or not to tweet? A primer on social media for pharmacists. J Am Coll Clin Pharm 2019;2:554-62.

If you would like to serve as a reviewer for JACCP or Pharmacotherapy, please submit your curriculum vitae to Keri Sims ([email protected]).